A carregar...
SARS-CoV-2 cell entry and targeted antiviral development
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the pandemic coronavirus disease 2019 (COVID-19), which threatens human health and public safety. In the urgent campaign to develop anti-SARS-CoV-2 therapies, the initial entry step is one of the most appealing ta...
Na minha lista:
| Publicado no: | Acta Pharm Sin B |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8117542/ https://ncbi.nlm.nih.gov/pubmed/34002130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2021.05.007 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|